Ozempic

It’s a funny thing, being a feminist surrounded by women on weight-loss drugs. As someone who recognises the health risks of being clinically obese, I’ve never been a fat liberationist – but pretty much all of us used to be against prescribed beauty standards. In practice this meant we would critique the harmful impacts of the ‘size zero’ or ‘heroin chic’ trends rather than obsess over having gained a few pounds over Christmas. Yet, with the rise of weight-loss jabs, skinniness has become a norm rather than a feminist discussion. And twee ideas about ‘being good’ or ‘cheating’ have been replaced by – well – feeling too nauseous to cheat

It’s already known for whittling down waistlines – and now Ozempic looks set to have the same effect on wine consumption. Research recently published in the journal JAMA Psychiatry found semaglutide, the weight loss medication also sold under the brand name Wegovy, reduced cravings in people with alcohol use disorder.  The study by California’s USC Institute for Addiction Science divided 48 participants into two groups and found those injected with semaglutide drank less in each sitting than those offered a placebo. It is not the first research to link the jabs – originally designed as a diabetes treatment – to lower incidence of substance abuse. In October it was suggested in